Skip to main content
KRYS logo
KRYS
(NASDAQ)
Krystal Biotech, Inc.
$260.95-- (--)
Loading... - Market loading

Krystal Biotech (KRYS) Stock Price & Financial Analysis

Krystal Biotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$252.62 - $260.99
52-Week High$298.30
52-Week Low$122.80
Open$252.62
Volume203.76K
Average Volume (3M)203.76K
Market Cap7.82B
Shares Outstanding29.95M
P/E Ratio (TTM)37.86
Forward P/E18.93
Price to Sales (P/S)19.93
Price to Book (P/B)6.36
EV/EBITDA45.07
Revenue (TTM)389.13M
Net Income (TTM)204.83M
Free Cash Flow (TTM)188.91M
EPS (TTM)$6.84
Profit Margin52.64%
Operating Margin41.45%
Return on Equity (ROE)16.80%
Debt to Equity0.01
50-Day MA$265.90
200-Day MA$204.55
52-Week Change48.30%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Krystal Biotech

What is the current stock price for KRYS?

As of the latest trading session, KRYS stock trades at $260.95. The 52-week range is $122.80–$298.30, with a day range of $252.62–$260.99.

What is the P/E ratio for KRYS?

Krystal Biotech's trailing P/E ratio is 37.9, meaning investors pay $37.9 for every $1 of annual earnings. The forward P/E is 18.9, reflecting analyst expectations for future earnings. Krystal Biotech operates in the Healthcare sector.

Does KRYS pay dividends?

Krystal Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KRYS?

Based on 9 analysts, the consensus for KRYS is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KRYS?

Krystal Biotech's market capitalization is $7.82B, classifying it as a mid-cap company. Krystal Biotech operates in the Healthcare sector within the Biotechnology industry.